What do we know?
Science · Biotechnology · Strategy
Science. Biotechnology. Impact.
I turn evidence across exosomes, peptides, NAD⁺, neuroscience and health technology into clearer strategy.
Where is the value?
Who matters?
Scientific Focus
Not what is new. What matters.
Mechanism, human evidence, limitations and real translational potential.
Go deeper into the science ↗Exosomes
Cargo · communication · biomarkers · translation
Peptides
Signal · target · mechanism · evidence
NAD⁺
Energy · redox · mitochondria · ageing
Technology Focus
Selected fields. Clear perspective.
Technologies with scientific meaning and credible real-world value.
Neurology & Neurotechnology
Neuromodulation, neurodiagnostics, digital neurology and next-generation neurological care technologies.
Explore the field ↗Rehabilitation Technologies
Robotic rehabilitation, motion analysis and technology-enabled functional recovery.
Explore the field ↗Digital Health & AI
Clinical decision support, remote monitoring and AI-enabled healthcare solutions.
Explore the field ↗Advanced Medical Technologies
Selected platforms with the potential to improve diagnosis, treatment, monitoring or clinical workflows.
Explore the field ↗Emerging Biotechnologies
New approaches followed selectively through evidence quality, safety and credible clinical value.
Explore the field ↗Working Ecosystem
Right technology. Right institution. Right context.
Scientific value matters when it meets real-world reality.
Hospitals & Healthcare Organisations
Healthcare organisations assessing where and how a new technology can create practical value.
Assess it for your institution ↗Specialist Clinics & Rehabilitation Centres
Centres evaluating new solutions in neurology, rehabilitation and technology-enabled care.
Discuss the clinical use case ↗Health Technology Companies
International developers looking to understand Türkiye and reach the right institutions.
Assess the Türkiye market ↗Academic & Clinical Collaborations
Selected projects requiring scientific assessment, expert input or evidence development.
Discuss a scientific collaboration ↗Scientific Foundation
Science, clinical need and market reality at the same table.
I combine a background in biology, pharmacology and neuroscience with field and business-development experience across pharmaceuticals, biotechnology and medical technology.
Scientific Perspective
Read the evidence. Ignore the noise.
Referenced. Critical. Applicable.
Exosomes and microRNA biomarkers in Parkinson’s disease
A critical look at exosomes as biomarkers, carriers of pathology and possible therapeutic platforms in Parkinson’s disease.
Explore the writing ↗Mitochondria and cellular quality control in Alzheimer’s disease
A scientific perspective on mitochondrial dysfunction, proteostasis and cellular stress in Alzheimer’s biology.
Explore the writing ↗The role of artificial intelligence in clinical decision-making
Assessing clinical AI through safety, workflow and real-world applicability rather than algorithm performance alone.
Explore the writing ↗Evidence, applicability and market value in health technology
How a health technology moves from scientific evidence to credible use and a sustainable market model.
Explore the writing ↗Strategic Cooperation
If you have an idea, let’s clarify the evidence and the route.
Scientific consulting · biotechnology · Türkiye market